Our collaboration with A/Prof. Andrew Holden and the team at Auckland Vascular Research in New Zealand spans over a decade and we are always proud to be the CRO working on exciting clinical trials with them.

Hot off the press in Vascular Specialist last month, is an article on one of our ongoing FIH studies, Efemoral I – the use of a novel, balloon-expandable, resorbable, drug-eluting device for the treatment of symptomatic peripheral arterial occlusive disease from stenosis or occlusion of the femoropopliteal or external iliac artery. Read more here.